BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15988604)

  • 1. [Haemostaseology].
    Schrör K
    Internist (Berl); 2005 Aug; 46(8):873-8, 880-1. PubMed ID: 15988604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New targets for antithrombotic drugs.
    Thiagarajan P
    Am J Cardiovasc Drugs; 2002; 2(4):227-35. PubMed ID: 14727968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic drugs in vascular medicine: a historical perspective.
    Schrör K
    Semin Vasc Med; 2003 May; 3(2):97-105. PubMed ID: 15199472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
    Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
    Bird JE; Giancarli MR; Allegretto N; Barbera F; Wong P; Schumacher WA; Ogletree ML; Seiffert D
    Thromb Res; 2008; 123(1):146-58. PubMed ID: 18479740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in antiplatelet and antithrombotic therapy.
    Verstraete M
    Eur Heart J; 1995 Nov; 16 Suppl L():16-23. PubMed ID: 8869014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current and future antiplatelet therapies: emphasis on preserving haemostasis.
    McFadyen JD; Schaff M; Peter K
    Nat Rev Cardiol; 2018 Mar; 15(3):181-191. PubMed ID: 29297508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New antithrombotic agents.
    Hirsh J; Weitz JI
    Lancet; 1999 Apr; 353(9162):1431-6. PubMed ID: 10227240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal Models of Thrombosis From Zebrafish to Nonhuman Primates: Use in the Elucidation of New Pathologic Pathways and the Development of Antithrombotic Drugs.
    Jagadeeswaran P; Cooley BC; Gross PL; Mackman N
    Circ Res; 2016 Apr; 118(9):1363-79. PubMed ID: 27126647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Where to look for progress in antithrombotic treatments?].
    Samama MM
    Rev Prat; 1999 Oct; 49(15):1664-8. PubMed ID: 10581998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in antithrombotic agents.
    Chakrabarti R; Das SK
    Cardiovasc Hematol Agents Med Chem; 2007 Jul; 5(3):175-85. PubMed ID: 17630943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Haemostasis and antithrombotic drugs: pharmacology and novel therapeutic approaches].
    Schrör K
    Hamostaseologie; 2006 May; 26(2):104-5. PubMed ID: 16676051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antithrombotic drugs on the horizon.
    Ruef J; Katus HA
    Expert Opin Investig Drugs; 2003 May; 12(5):781-97. PubMed ID: 12720490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of anticoagulation.
    Hoppensteadt DA; Jeske W; Walenga J; Fareed J
    Semin Respir Crit Care Med; 2008 Feb; 29(1):90-9. PubMed ID: 18302091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and anticoagulant therapy in patients undergoing percutaneous transluminal coronary angioplasty.
    Barry WL; Sarembock IJ
    Cardiol Clin; 1994 Aug; 12(3):517-35. PubMed ID: 7805084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why we should not skip aspirin in cardiovascular prevention.
    Schrör K
    Hamostaseologie; 2016; 36(1):33-43. PubMed ID: 25891122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An antithrombotic therapy from the viewpoint of hematology].
    Asakura H
    Brain Nerve; 2015 Jan; 67(1):83-91. PubMed ID: 25585437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
    Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
    J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.